Can Bellicum Pharmaceuticals Stock Bounce Back? – nwitimes.com
nwitimes.com |
Can Bellicum Pharmaceuticals Stock Bounce Back?
nwitimes.com Why did this bad news for another biotech hurt Bellicum? It's using the same basic technology as Juno — chimeric antigen receptor T–cell (CAR-T) therapy. With CAR-T therapies, patients' T–cells (white blood cells produced in the thymus gland that are … |
